Sanofi targets high single digit sales growth in 2026, plans share buyback
Sanofi(US:SNY) Reuters·2026-01-29 14:33French drugmaker Sanofi said on Thursday it expects sales to grow by a high-single-digit percentage in 2026, banking on strong demand for its blockbuster asthma drug Dupixent and some newer medicines. ...